Elite is developing differentiated niche generic products for future growth.  Elite’s focus is on solid oral dose products that are hard to formulate, such as extended-release products and products that we believe have competitive advantages.  Elite also continues to evaluate contract development, contract manufacturing, and in-licensing opportunities.  Updates on development projects will be provided upon achieving key milestones.